Taken together, these data suggest that TSPO may play a role in the pathophysiological response to obesity through modulation of mitochondrial activity, and that loss of this protein could impact the development of obesity and associated pro‐inflammatory changes leading to low‐grade tissue inflammation and an impact on systemic glucose homeostasis.32 The gene discussed is TSPO; the disease is obesity due to melanocortin 4 receptor deficiency.